n.beaulieu
Submits third-party assay reports on material purchased directly. Based in Zaragoza.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
7
n=7
Annotations
0
n=0
Median purity submitted
98.68%
n=7
Suppliers covered
5
n=7
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041671 | Liraglutide | QSC | QSC-2605-W8232 | Janoshik | 2026-Q3 | 98.83 | 5.63 | 94.7 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-041908 | Epitalon | HYB | HYB-2603-U4136 | Janoshik | 2026-Q2 | 99.62 | 7.00 | — | Buyer-sourced | 0 | FAIL |
| AX-2026-043715 | GHRP-6 | BCH | BCH-2603-Y7240 | Nordanalyt | 2026-Q2 | 98.72 | 5.15 | 89.0 | Buyer-sourced | 1 | FAIL |
| AX-2026-043262 | Tirzepatide | SSA | SSA-2508-P6978 | Nordanalyt | 2026-Q1 | 97.68 | 5.46 | — | Buyer-sourced | 0 | PASS |
| AX-2025-021244 | TB-500 | WXT | WXT-2502-A5978 | VendorInvestigate | 2025-Q3 | 97.85 | 2.70 | — | Buyer-sourced | 0 | FAIL |
| AX-2025-021307 | Pemvidutide | BCH | BCH-2506-G6830 | PeptideMeter | 2025-Q3 | 97.77 | 5.40 | 94.5 | Buyer-sourced | 0 | PASS |
| AX-2024-004618 | Exenatide | HYB | HYB-2407-J3695 | Janoshik | 2024-Q3 | 98.68 | 4.85 | 90.7 | Buyer-sourced | 1 | MARGINAL |